Maruho Report 2023
5/60

Maruho Report 20234We actively invest management resources in strengthening our production bases and production systems to provide a stable supply of high-quality pharmaceuticals, and contribute to improve the quality of life of patients with our quality control system and top-class production capabilities of topical drugs in Japan.We collect and provide information on our pharmaceuticals to medical professionals to promote their proper use, and at the same time, we disseminate appropriate information about diseases to patients.In all of our activities, we comply with laws, regulations, and international norms, and actively research and develop innovative pharmaceuticals that contribute to the advancement of medicine. We provide a stable supply of pharmaceuticals with excellent efficacy, safety, and quality. We also offer scientific information and promptly collect, evaluate, and communicate information post sales.quality managementProduction andInformation collectionand provisionReliability assurance

元のページ  ../index.html#5

このブックを見る